A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)

Completed · Phase 2

Conditions studied: Insulin Resistance, Diabetes Mellitus

In brief

The goal of this study is to aggressively treat insulin resistance and its clinical manifestations when they first appear in childhood, and to prevent the subsequent progression towards impaired glucose tolerance and type-2 diabetes. In the process of this clinical trial, we will learn more about the early manifestations of insulin resistance, its treatment, and its relationship to obesity and type-2 diabetes through parallel in-vivo and in-vitro studies.

Key facts

Study ID

NCT00015626

Run by

National Center for Research Resources (NCRR)

People needed

300

Last updated by the study team

2005-06-24

Who can join

Age: 5 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Obese patients (wt > 95th percentile for age, for adults increased BMI > 27) greater than 5 years of age
• And/or presence of complications of insulin resistance such as acanthosis nigricans, dyslipidemia, elevated blood pressure, hyperandrogenism
• Siblings and parents of patients with insulin resistance. Siblings and parents will be included only in the case of documented insulin resistance in the index subject. Insulin resistance will be documented by OGTT and/or IVGTT.
• Family history of type II diabetes.

You may not qualify if…

• Critically ill patients, patients will congestive heart failure, renal or liver insufficiency
• Inability to give consent.
• History of poor compliance with physician's recommendations

Where it is running

• Cornell University — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.